Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?

por Tomuleasa C, Cucuianu A, Aldea M, Berindan-Neagoe I
Publicado 2013

Nanopharmacology in translational hematology and oncology

por Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I
Publicado 2014

MRI-based identification of undifferentiated cells: looking at the two faces of Janus

por Tomuleasa C, Florian IS, Berce C, Irimie A, Berindan-Neagoe I, Cucuianu A
Publicado 2014

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies

por Kojima S, Cucuianu A, Takahashi Y, Berindan-Neagoe I, Florian IS, Dima D, Tomuleasa C
Publicado 2014

In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in Crl:CD1(ICR) mice

por Berce C, Lucan C, Petrushev B, Boca S, Miclean M, Sarpataki O, Astilean S, Buzoianu A, Tomuleasa C, Bojan A
Publicado 2016

Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles

por Orza A, Soriţău O, Tomuleasa C, Olenic L, Florea A, Pana O, Bratu I, Pall E, Florian S, Casciano D, Biris AS
Publicado 2013

Small molecules against B-RAF (BRAF) Val600Glu (V600E) single mutation

por Zaharie F, Cojocneanu-Petric R, Muresan M, Frinc I, Dima D, Petrushev B, Tanase A, Berce C, Chitic M, Berindan-Neagoe I, Pileczki V, Irimie A, Tomuleasa C
Publicado 2015

Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy

por Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I
Publicado 2016